Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (110) GO Terms (5) Nucleotides (168) Proteins (72) Interactants (158) Wiki
XB-GENEPAGE-995620

Papers associated with gria1



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action., Nomura T, Nishizaki T., Dev Biol. July 7, 2000; 870 (1-2): 157-62.

The contributions of GluR2 to allosteric modulation of AMPA receptors., Cotton JL, Partin KM., Neuropharmacology. January 1, 2000; 39 (1): 21-31.

In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus., White HS, McCabe RT, Armstrong H, Donevan SD, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarmann I, Hollmann M, Olivera BM., J Pharmacol Exp Ther. January 1, 2000; 292 (1): 425-32.

A desensitization-inhibiting mutation in the glutamate binding site of rat alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is dominant in heteromultimeric complexes., Thalhammer A, Morth T, Strutz N, Hollmann M., Neurosci Lett. December 31, 1999; 277 (3): 161-4.

Potentiating effects of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyaceta mide (PEPA) on excitatory synaptic transmission in dentate granule cells., Nakagawa T, Iino M, Sekiguchi M, Wada K, Ozawa S., Neurosci Res. December 1, 1999; 35 (3): 217-23.

Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA., Stensbøl TB, Borre L, Johansen TN, Egebjerg J, Madsen U, Ebert B, Krogsgaard-Larsen P., Eur J Pharmacol. September 10, 1999; 380 (2-3): 153-62.

Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP., Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1999; 360 (3): 242-8.

Investigation by ion channel domain transplantation of rat glutamate receptor subunits, orphan receptors and a putative NMDA receptor subunit., Villmann C, Strutz N, Morth T, Hollmann M., Eur J Neurosci. May 1, 1999; 11 (5): 1765-78.

Arachidonic acid potentiates currents through Ca2+-permeable AMPA receptors by interacting with a CaMKII pathway., Nishizaki T, Matsuoka T, Nomura T, Enikolopov G, Sumikawa K., Brain Res Mol Brain Res. April 6, 1999; 67 (1): 184-9.

Subtype-specific effects of lithium on glutamate receptor function., Karkanias NB, Papke RL., J Neurophysiol. April 1, 1999; 81 (4): 1506-12.

Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid., Møller EH, Egebjerg J, Brehm L, Stensbøl TB, Johansen TN, Madsen U, Krogsgaard-Larsen P., Chirality. January 1, 1999; 11 (10): 752-9.

Neurosteroid modulation of recombinant ionotropic glutamate receptors., Yaghoubi N, Malayev A, Russek SJ, Gibbs TT, Farb DH., Dev Biol. August 24, 1998; 803 (1-2): 153-60.

Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes., Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ., J Pharmacol Exp Ther. July 1, 1998; 286 (1): 334-40.

The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors., Donevan SD, Beg A, Gunther JM, Twyman RE., J Pharmacol Exp Ther. May 1, 1998; 285 (2): 539-45.

Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures., Sekiguchi M, Takeo J, Harada T, Morimoto T, Kudo Y, Yamashita S, Kohsaka S, Wada K., Br J Pharmacol. April 1, 1998; 123 (7): 1294-303.

Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes., Wahl P, Anker C, Traynelis SF, Egebjerg J, Rasmussen JS, Krogsgaard-Larsen P, Madsen U., Mol Pharmacol. March 1, 1998; 53 (3): 590-6.

A tetrameric subunit stoichiometry for a glutamate receptor-channel complex., Mano I, Teichberg VI., Neuroreport. January 26, 1998; 9 (2): 327-31.

Structural determinants of the blocker binding site in glutamate and NMDA receptor channels., Ferrer-Montiel AV, Merino JM, Planells-Cases R, Sun W, Montal M., Neuropharmacology. January 1, 1998; 37 (2): 139-47.

Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives., Magazanik LG, Buldakova SL, Samoilova MV, Gmiro VE, Mellor IR, Usherwood PN., J Physiol. December 15, 1997; 505 ( Pt 3) 655-63.

Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists., Igarashi K, Shirahata A, Pahk AJ, Kashiwagi K, Williams K., J Pharmacol Exp Ther. November 1, 1997; 283 (2): 533-40.

Kainate binding proteins possess functional ion channel domains., Villmann C, Bull L, Hollmann M., J Neurosci. October 15, 1997; 17 (20): 7634-43.

A serum factor potentiates ACh and AMPA receptor currents via differential signal transduction pathways., Nishizaki T, Matsuoka T, Nomura T, Sumikawa K., Biochem Biophys Res Commun. September 18, 1997; 238 (2): 565-8.

Comparison of the agonist binding site of homomeric, heteromeric, and chimeric GluR1(o) and GluR3(o) AMPA receptors., Banke TG, Schousboe A, Pickering DS., J Neurosci Res. July 15, 1997; 49 (2): 176-85.

Effects of external calcium on zinc modulation of AMPA receptors., Dreixler JC, Leonard JP., Dev Biol. March 28, 1997; 752 (1-2): 170-4.

Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes., Blaschke M, Gremmels D, Everts I, Weigand E, Heinemann SF, Hollmann M, Keller BU., Neuropharmacology. January 1, 1997; 36 (11-12): 1489-501.

Thiocyanate ions inhibit AMPA-activated currents in recombinant non-NMDA receptors expressed in Xenopus laevis oocytes: the role of the GluR2 subunit., Eugène D, Moss SJ, Smart TG., Eur J Neurosci. September 1, 1996; 8 (9): 1983-93.

A single tryptophan on M2 of glutamate receptor channels confers high permeability to divalent cations., Ferrer-Montiel AV, Sun W, Montal M., Biophys J. August 1, 1996; 71 (2): 749-58.

A venus flytrap mechanism for activation and desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors., Mano I, Lamed Y, Teichberg VI., J Biol Chem. June 28, 1996; 271 (26): 15299-302.

Pentameric subunit stoichiometry of a neuronal glutamate receptor., Ferrer-Montiel AV, Montal M., Proc Natl Acad Sci U S A. April 2, 1996; 93 (7): 2741-4.

Anesthetics produce subunit-selective actions on glutamate receptors., Dildy-Mayfield JE, Eger EI, Harris RA., J Pharmacol Exp Ther. March 1, 1996; 276 (3): 1058-65.

CDNA cloning of chick brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors reveals conservation of structure, function and post-transcriptional processes with mammalian receptors., Paperna T, Lamed Y, Teichberg VI., Brain Res Mol Brain Res. February 1, 1996; 36 (1): 101-13.

New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors., Fletcher EJ, Lodge D., Pharmacol Ther. January 1, 1996; 70 (1): 65-89.

Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine., Ferrer-Montiel AV, Sun W, Montal M., Proc Natl Acad Sci U S A. August 15, 1995; 92 (17): 8021-5.

Identification of a Ca2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in non-N-methyl-D-aspartate glutamate receptors., Yakel JL, Vissavajjhala P, Derkach VA, Brickey DA, Soderling TR., Proc Natl Acad Sci U S A. February 28, 1995; 92 (5): 1376-80.

N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1., Hollmann M, Maron C, Heinemann S., Neuron. December 1, 1994; 13 (6): 1331-43.

A deletion in the second cytoplasmic loop of GluR3 produces a dominant negative mutant of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor., Sekiguchi M, Doi K, Zhu WS, Watase K, Yokotani N, Wada K, Wenthold RJ., J Biol Chem. May 20, 1994; 269 (20): 14559-65.

Activation of protein kinase C inhibits kainate-induced currents in oocytes expressing glutamate receptor subunits., Dildy-Mayfield JE, Harris RA., J Neurochem. April 1, 1994; 62 (4): 1639-42.

Subunit-specific enhancement of glutamate receptor responses by zinc., Dreixler JC, Leonard JP., Brain Res Mol Brain Res. March 1, 1994; 22 (1-4): 144-50.

Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes., Sharp RL, May PC, Mayne NG, Snyder YM, Burnett JP., Eur J Pharmacol. January 1, 1994; 266 (1): R1-2.

Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins., Brackley PT, Bell DR, Choi SK, Nakanishi K, Usherwood PN., J Pharmacol Exp Ther. September 1, 1993; 266 (3): 1573-80.

A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor channels., Blaschke M, Keller BU, Rivosecchi R, Hollmann M, Heinemann S, Konnerth A., Proc Natl Acad Sci U S A. July 15, 1993; 90 (14): 6528-32.

Are chimeric kainate/N-methyl-D-aspartate receptors expressed in Xenopus oocytes from mammalian and amphibian RNA?, Brackley PT, Usherwood PN., J Pharmacol Exp Ther. May 1, 1993; 265 (2): 910-9.

Neurotransmitter receptors and voltage-dependent Ca2+ channels encoded by mRNA from the adult corpus callosum., Matute C, Miledi R., Proc Natl Acad Sci U S A. April 15, 1993; 90 (8): 3270-4.

Identification of a subunit-specific antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor channels., Keller BU, Blaschke M, Rivosecchi R, Hollmann M, Heinemann SF, Konnerth A., Proc Natl Acad Sci U S A. January 15, 1993; 90 (2): 605-9.

Expression of neurotransmitter receptors by mRNAs from neurons developing in vitro: a Xenopus oocyte expression study., Wahl P, Ragsdale D, Schousboe A, Miledi R., J Neurochem. January 1, 1993; 60 (1): 57-65.

Agonist- and subunit-dependent potentiation of glutamate receptors by a nootropic drug aniracetam., Tsuzuki K, Takeuchi T, Ozawa S., Brain Res Mol Brain Res. November 1, 1992; 16 (1-2): 105-10.

N-acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytes., Sekiguchi M, Wada K, Wenthold RJ., FEBS Lett. October 26, 1992; 311 (3): 285-9.

Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels., Dingledine R, Hume RI, Heinemann SF., J Neurosci. October 1, 1992; 12 (10): 4080-7.

Calcium influx through subunits GluR1/GluR3 of kainate/AMPA receptor channels is regulated by cAMP dependent protein kinase., Keller BU, Hollmann M, Heinemann S, Konnerth A., EMBO J. March 1, 1992; 11 (3): 891-6.

Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors., Sun W, Ferrer-Montiel AV, Schinder AF, McPherson JP, Evans GA, Montal M., Proc Natl Acad Sci U S A. February 15, 1992; 89 (4): 1443-7.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 ???pagination.result.next???